An expert in clinical trial design suggests a “middle ground” alternative to turning away entirely from the drug model in trials for dietary supplement health claims.
“The goal of our industry is to promote health and, therefore, outcomes should measure health indices and statistical models should...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?